Literature DB >> 25193515

Transcervical ultrasound identifies primary tumor site of unknown primary head and neck squamous cell carcinoma.

Wojciech K Mydlarz1, Jia Liu1, Ray Blanco2, Carole Fakhry3.   

Abstract

Entities:  

Keywords:  head and neck squamous cell carcinoma; human papillomavirus; oropharyngeal cancer; ultrasound; unknown primary

Mesh：

Year:  2014        PMID： 25193515      PMCID： PMC4696058          DOI： 10.1177/0194599814549181

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN： 0194-5998            Impact factor:   3.497


× No keyword cloud information.
  5 in total

Review 1.  Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches.

Authors:  Primož Strojan; Alfio Ferlito; Jesus E Medina; Julia A Woolgar; Alessandra Rinaldo; K Thomas Robbins; Johannes J Fagan; William M Mendenhall; Vinidh Paleri; Carl E Silver; Kerry D Olsen; June Corry; Carlos Suárez; Juan P Rodrigo; Johannes A Langendijk; Kenneth O Devaney; Luiz P Kowalski; Dana M Hartl; Missak Haigentz; Jochen A Werner; Phillip K Pellitteri; Remco de Bree; Gregory T Wolf; Robert P Takes; Eric M Genden; Michael L Hinni; Vanni Mondin; Ashok R Shaha; Leon Barnes
Journal:  Head Neck       Date:  2011-10-27       Impact factor: 3.147

2.  Ultrasound-guided fine-needle aspiration of the tongue base: a cadaver feasibility study.

Authors:  Ryan K Meacham; John D Boughter; Merry E Sebelik
Journal:  Otolaryngol Head Neck Surg       Date:  2012-05-02       Impact factor: 3.497

3.  The use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers.

Authors:  Carole Fakhry; Nishant Agrawal; Joseph Califano; Barbara Messing; Jia Liu; John Saunders; Patrick Ha; Stephanie Coquia; Ulrike Hamper; Maura Gillison; Ray Blanco
Journal:  Oral Oncol       Date:  2014-05-10       Impact factor: 5.337

4.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

5.  Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.

Authors:  Maura L Gillison; Gypsyamber D'Souza; William Westra; Elizabeth Sugar; Weihong Xiao; Shahnaz Begum; Raphael Viscidi
Journal:  J Natl Cancer Inst       Date:  2008-03-11       Impact factor: 13.506
  5 in total
  4 in total

1.  Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer.

Authors:  Krystle A Lang Kuhs; C Burton Wood; Jamie Wiggleton; Joseph M Aulino; Brian Latimer; Derek K Smith; Noemi Bender; Sarah Rohde; Kyle Mannion; Young Kim; Robert Sinard; Alexander Langerman; Arthur Fleischer; Carole Fakhry; Tim Waterboer; James L Netterville
Journal:  Cancer       Date:  2020-03-04       Impact factor: 6.860

Review 2.  HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection.

Authors:  Mary Roz Timbang; Michael W Sim; Arnaud F Bewley; D Gregory Farwell; Avinash Mantravadi; Michael G Moore
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

3.  Usefulness of ultrasound for assessing the primary tumor of hypopharyngeal carcinoma.

Authors:  Takahiro Fukuhara; Eriko Matsuda; Yuiko Hattori; Ryohei Donishi; Hiroaki Ehara; Kazunori Fujiwara; Hiromi Takeuchi
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-11-22

4.  Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.

Authors:  Ryan Suk; Parag Mahale; Kalyani Sonawane; Andrew G Sikora; Jagpreet Chhatwal; Kathleen M Schmeler; Keith Sigel; Scott B Cantor; Elizabeth Y Chiao; Ashish A Deshmukh
Journal:  JAMA Netw Open       Date:  2018-09-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.